Statements (58)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:biotechnology
|
| gptkbp:acquired |
certain assets from Confluence Pharmaceuticals
|
| gptkbp:acquisition |
acquired by a larger pharmaceutical company in the past
|
| gptkbp:advocacy |
supports patient advocacy initiatives
|
| gptkbp:business_model |
operates on a biotechnology business model
|
| gptkbp:can_lead_to |
gptkb:ATI-501
|
| gptkbp:ceo |
gptkb:Dr._Neal_Walker
|
| gptkbp:clinical_trial |
publishes clinical data in scientific journals
conducts clinical research studies clinical stage company conducts trials in various phases announces clinical trial results to the public conducts clinical trials for drug development manages clinical trial phases effectively |
| gptkbp:collaborations |
engages in collaborations with academic institutions
|
| gptkbp:community_engagement |
engages with the community through outreach programs
|
| gptkbp:develops |
therapeutics for skin diseases
|
| gptkbp:employees |
employs a team of scientists and professionals
|
| gptkbp:focus |
maintains a patient-focused approach
|
| gptkbp:focuses_on |
dermatology
|
| gptkbp:founded |
gptkb:2012
|
| gptkbp:funding |
has received venture capital funding
|
| gptkbp:has_advisory_board |
has a scientific advisory board
|
| gptkbp:head_of_state |
engages in business development activities
|
| gptkbp:headquarters |
gptkb:Wayne,_Pennsylvania
|
| gptkbp:healthcare |
engages with healthcare professionals for insights
pursues therapeutic innovation in dermatology. |
| https://www.w3.org/2000/01/rdf-schema#label |
Aclaris Therapeutics
|
| gptkbp:instruction_set |
has a diverse pipeline of candidates
|
| gptkbp:invention |
holds multiple patents for its technologies
|
| gptkbp:investment |
gptkb:public_company
provides investor relations information receives investments from various sources |
| gptkbp:investment_focus |
focuses on the dermatology market
|
| gptkbp:known_for |
Aclaris' proprietary technology platform
|
| gptkbp:leadership |
has a leadership team with extensive experience
|
| gptkbp:market |
conducts market research to inform strategies
|
| gptkbp:market_launch |
plans product launches in the future
|
| gptkbp:marketing_strategy |
develops a market strategy for its products
|
| gptkbp:mission |
to improve the lives of patients with skin diseases
|
| gptkbp:partnerships |
collaborates with other pharmaceutical companies
forms strategic partnerships with other firms |
| gptkbp:product |
develops product candidates for various indications
|
| gptkbp:products |
Aclaris has products in development
|
| gptkbp:publications |
produces scientific publications related to its research
|
| gptkbp:regulatory_compliance |
prepares regulatory submissions for its products
seeks regulatory approval for its products |
| gptkbp:research_and_development |
invests in research and development activities
|
| gptkbp:research_areas |
autoimmune diseases
explores innovative therapeutic approaches |
| gptkbp:research_focus |
immune-mediated skin conditions
|
| gptkbp:therapeutic_indications |
targets specific therapeutic indications in dermatology
|
| gptkbp:traded_on |
gptkb:NASDAQ
|
| gptkbp:treatment |
aims to improve clinical outcomes for patients
|
| gptkbp:website |
www.aclaristx.com
|
| gptkbp:bfsParent |
gptkb:Regeneron_Pharmaceuticals
gptkb:Regeneron |
| gptkbp:bfsLayer |
4
|